These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 22259602)

  • 41. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
    Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
    Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
    Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison.
    Ijsselmuiden AJ; Ezechiels J; Westendorp IC; Tijssen JG; Kiemeneij F; Slagboom T; van der Wieken R; Tangelder G; Serruys PW; Laarman G
    Am Heart J; 2004 Sep; 148(3):467-74. PubMed ID: 15389234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
    Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
    [No Abstract]   [Full Text] [Related]  

  • 46. Complete Revascularization with Multivessel PCI for Myocardial Infarction.
    Mehta SR; Wood DA; Storey RF; Mehran R; Bainey KR; Nguyen H; Meeks B; Di Pasquale G; López-Sendón J; Faxon DP; Mauri L; Rao SV; Feldman L; Steg PG; Avezum Á; Sheth T; Pinilla-Echeverri N; Moreno R; Campo G; Wrigley B; Kedev S; Sutton A; Oliver R; Rodés-Cabau J; Stanković G; Welsh R; Lavi S; Cantor WJ; Wang J; Nakamya J; Bangdiwala SI; Cairns JA;
    N Engl J Med; 2019 Oct; 381(15):1411-1421. PubMed ID: 31475795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute multivessel revascularization improves 1-year outcome in ST-elevation myocardial infarction: a nationwide study cohort from the AMIS Plus registry.
    Jeger R; Jaguszewski M; Nallamothu BN; Lüscher TF; Urban P; Pedrazzini GB; Erne P; Radovanovic D;
    Int J Cardiol; 2014 Mar; 172(1):76-81. PubMed ID: 24461983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
    Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials.
    Bajraktari G; Bytyçi I; Henein MY; Alfonso F; Ahmed A; Jashari H; Bhatt DL
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100549. PubMed ID: 32577495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complete revascularization for patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: a meta-analysis of randomized trials.
    Bajraktari G; Jashari H; Ibrahimi P; Alfonso F; Jashari F; Ndrepepa G; Elezi S; Henein MY
    Coron Artery Dis; 2018 May; 29(3):204-215. PubMed ID: 29346126
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
    Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
    JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Complete or incomplete coronary revascularisation in patients with myocardial infarction and multivessel disease: a propensity score analysis from the "real-life" BleeMACS (Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome) registry.
    Quadri G; D'Ascenzo F; Moretti C; D'Amico M; Raposeiras-Roubín S; Abu-Assi E; Henriques JPS; Saucedo J; González-Juanatey JR; Wilton SB; Kikkert WJ; Nuñez-Gil I; Ariza-Sole A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Huczek Z; Nie SP; Fujii T; Correia L; Kawashiri MA; García-Acuña JM; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Omedè P; Montefusco A; Giordana F; Scarano S; Kowara M; Filipiak K; Wang X; Yan Y; Fan JY; Ikari Y; Nakahashi T; Sakata K; Yamagishi M; Kalpak O; Kedev S; Varbella F; Gaita F
    EuroIntervention; 2017 Jul; 13(4):407-414. PubMed ID: 28169217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
    Bainey KR; Mehta SR; Lai T; Welsh RC
    Am Heart J; 2014 Jan; 167(1):1-14.e2. PubMed ID: 24332136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry.
    Pimor A; Auffret V; Didier R; Delaunay R; Filippi E; Hacot JP; Saouli D; Rouault G; Druelles P; Bot E; Coudert I; Boulanger B; Le Guellec M; Boulmier D; Leurent G; Bedossa M; Gilard M; Le Breton H
    Arch Cardiovasc Dis; 2018 Nov; 111(11):656-665. PubMed ID: 29229216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Culprit only versus complete coronary revascularization during primary PCI.
    Qarawani D; Nahir M; Abboud M; Hazanov Y; Hasin Y
    Int J Cardiol; 2008 Jan; 123(3):288-92. PubMed ID: 17428557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
    Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
    Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomised trial of target-vessel versus multi-vessel revascularisation in ST-elevation myocardial infarction: major adverse cardiac events during long-term follow-up.
    Politi L; Sgura F; Rossi R; Monopoli D; Guerri E; Leuzzi C; Bursi F; Sangiorgi GM; Modena MG
    Heart; 2010 May; 96(9):662-7. PubMed ID: 19778920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Instantaneous wave-free ratio-guided revascularization of non-culprit lesion in patients with ST-segment elevation myocardial infarction and multivessel coronary disease: design and rationale of the WAVE Registry.
    Musto C; Nusca A; Biondi-Zoccai G; DE Felice F; Scappaticci M; Nazzaro MS; Viscusi MM; Ceccacci A; Versaci F
    Minerva Cardiol Angiol; 2021 Jun; 69(3):291-298. PubMed ID: 33427419
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis of multivessel coronary artery revascularization versus culprit-only revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease.
    Bangalore S; Kumar S; Poddar KL; Ramasamy S; Rha SW; Faxon DP
    Am J Cardiol; 2011 May; 107(9):1300-10. PubMed ID: 21349487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.